Egfr Mutation Analysis

Summary

Mark G. Kris, MD. Chief, Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center in New York Discusses Dr. Geoffrey Oxnard describes a study that aims to identify non-smoking lung cancer patients who have a rare Nathan Pennell, MD, PhD, associate professor of Medicine at Cleveland Clinic, discusses the importance of Learn more about lung cancer at YouAndLungCancer.org This animation provides an overview of ... MD; Alexander Drilon, MD; and Jared Weiss, MD, provide insight on which At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 13–16 April 2016, Martin Reck, MD, ... Sanjay Popat, BSc, MBBS, FRCP, PhD, The Royal Marsden NHS Foundation Trust, London, UK, provides an overview on a ... For more info, visit: primrmed.com/cancer/lung-cancer In this video, we discuss Panelists Mark Socinski, MD, and Edward S. Kim, MD, discuss the rationale for EGFR, precision medicine, biomarker Samreen Ahmed, FRCP, MD, MBBS, MSc, University Hospitals of Leicester NHS Trust, Leicester, UK, discusses the Phase III ... Hazel O'Sullivan, MBBS, The Royal Marsden NHS Foundation Trust, London, UK, provides an overview of an investigation into ... Professor Sanjay Popat reviews the management of atypical